about
The intestinal archaea Methanosphaera stadtmanae and Methanobrevibacter smithii activate human dendritic cellsArchaea associated with human surfaces: not to be underestimatedBiofilm formation of mucosa-associated methanoarchaeal strains.Health- and disease-associated species clusters in complex natural biofilms determine the innate immune response in oral epithelial cells during biofilm maturation.Effects of antimicrobial peptides on methanogenic archaea.Microbiomarkers in inflammatory bowel diseases: caveats come with caviar.Immunogenic properties of the human gut-associated archaeon Methanomassiliicoccus luminyensis and its susceptibility to antimicrobial peptides.Archaea Are Interactive Components of Complex Microbiomes.The Human-Associated Archaeon Methanosphaera stadtmanae Is Recognized through Its RNA and Induces TLR8-Dependent NLRP3 Inflammasome Activation.First Insights into the Diverse Human Archaeome: Specific Detection of Archaea in the Gastrointestinal Tract, Lung, and Nose and on Skin.Faecal microbiota composition associates with abdominal pain in the general population.Metaorganisms in extreme environments: do microbes play a role in organismal adaptation?Normal gut microbiome in NMDA receptor encephalitisGut mycobiome of primary sclerosing cholangitis patients is characterised by an increase of Trichocladium griseum and Candida speciesThe role of the gut microbiome in the association between habitual anthocyanin intake and visceral abdominal fat in population-level analysisMinor compositional alterations in faecal microbiota after five weeks and five months storage at room temperature on filter papersA structured weight loss program increases gut microbiota phylogenetic diversity and reduces levels of Collinsella in obese type 2 diabetics: A pilot studyObese Individuals with and without Type 2 Diabetes Show Different Gut Microbial Functional Capacity and CompositionAlterations of the bile microbiome in primary sclerosing cholangitisConsistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis
P50
Q21559458-95B2B309-DD7F-48D4-99D8-5B5CE777F7EEQ28085673-3137280F-8002-41C9-82D1-85ED0D841520Q35214762-AD689691-481D-4721-9CFD-872D675F9DCDQ35248623-85CCEEAD-D40F-4551-BDF9-FE187BC79E35Q36171501-C83299AF-0685-493A-9B5E-59AABB358DD6Q40124428-8EB1F3ED-24E1-4A8D-999C-E2D338A52CD4Q42370752-F5EB6BE6-B8CE-49B2-B35C-092664D3DA57Q43031984-F2F6DFBC-F871-4351-B9F8-D346D7E61E20Q45891734-61DB7DB0-AF1D-4C10-ACFD-705081039D0EQ46261370-0FC2BF35-32BF-450E-942E-646D45EE1BD5Q48309890-A2D4AF5D-D544-4ABE-9C4E-3F369360F02DQ52337695-3F68825D-A7AA-4CA4-BF85-D6A4CB0B4A5AQ90780808-F7F65AD7-0C37-4CC9-BE04-281DCEB4385AQ90949889-A3FE4BA7-DBAB-48ED-8A4B-B3FB2E31C756Q91883096-DF31C75F-E1AF-48B3-A629-809E8053F4CDQ91933893-4C717BB2-C6A7-4C3C-8787-C065F51DFDCEQ91989750-579B3313-A710-4C32-BABF-10EBE9FEFA73Q92532899-04ADFBF4-FD7A-40F8-8FFB-D2AC825D67C4Q93051419-FAC1331B-495C-4521-979C-9E577D2101F1Q93095433-7DB1B784-4B79-4A3E-9477-41C5539C3C55
P50
description
bioloog
@nl
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
name
Corinna Bang
@ast
Corinna Bang
@en
Corinna Bang
@es
Corinna Bang
@nl
type
label
Corinna Bang
@ast
Corinna Bang
@en
Corinna Bang
@es
Corinna Bang
@nl
prefLabel
Corinna Bang
@ast
Corinna Bang
@en
Corinna Bang
@es
Corinna Bang
@nl
P214
P227
P19
P21
P214
P227
1045057444
P31
P496
0000-0001-6814-6151
P569
1984-01-01T00:00:00Z
P735
P7859
viaf-305435544